Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Takeda Pharmaceutical Co Ltd

TKPHFOTCEQUITYCurrent

Changes in Beneficial Ownership

Filed Aug 19, 2026Accepted Aug 19, 2026, 4:15 PM EDTFiling CIK 1395064Accession 0001493152-26-039214
Share

Structured filing — 4

ownership.xml

Open full document ↗

Filing details

Report period
2026-08-18
Issuer
TAKEDA PHARMACEUTICAL CO LTD
Issuer CIK
0001395064
Trading symbol
TAK

Reporting owner 1

Name
Greenway Nicola Deidre Petal
Reporting owner CIK
0002123546
Relationship
Officer
Officer title
Chief Human Resources Officer
Address
500 KENDALL STREET, CAMBRIDGE, MA, 02142

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
American Depositary Shares2026-08-18S · Form 412,980D18.113940,049D
Table key
S · Form 4
Sale on the market or privately
D
Direct

Signature 1

Signed
/s/ Samuel Ntonme, by power of attorney, for Nicola D. Greenway
Date
2026-08-19

Company context

Current securities

Historical securities (1)

Recent company filings

  1. 6-K filingOct 29, 2026
  2. 6-K filingOct 29, 2026
  3. 6-K filingSep 14, 2026
  4. 144 filingSep 10, 2026
  5. 144 filingSep 2, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.